Answers are grounded in this paper and cite their sources.
Demonstrates neuroprotective effects of pioglitazone in a rat model of α-synucleinopathy, suggesting therapeutic potential for Parkinson's disease.
Pioglitazone exhibited potential neuroprotective effects in a progressive αSN model, particularly under a prophylactic plus sustained treatment scheme. These findings support pioglitazone as a promising modifying therapy for PD and α-synucleinopathies.
No takes yet. Share an insight, caveat, or question.
Santiago-Balmaseda et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: